A Closer Look at Metastatic Breast Cancer with Dr. Robert Schneider

Most women who die of breast cancer die from metastatic disease, the spread of tumor cells to different parts of the body. Metastasis often results following treatment failure, but it also can occur decades after what was thought to be successful treatment. Currently, no curative therapies exist for metastatic breast cancer.

But today, the race to develop effective treatments for this disease is a key focus of some extraordinary research, much of it centering on cancer cells’ protein synthesis machinery and a protein called mTOR.

What’s the status of this research – and what might some practical outcomes look like?

I just had an incredibly thoughtful conversation with Dr. Robert Schneider. He’s the Associate Director of the NYU Cancer Institute, Director of Translational Cancer Research, and Co-director of the Breast Cancer Research Program at NYU School of Medicine. He’s also a BCRF Investigator since 2002.